Cuba uses Suma technology to diagnose infirmities in newborns
Havana, September 17 (RHC)-- The Center for Immune Testing (Centro de Inmunoensayo, CIE) is now using Suma technology to diagnose TIR (tripsinógeno inmunorreactivo) in newborns.
Suma is a Cuban technology, developed by professionals at the Center for Immune Testing. This is now the sixth infirmity in newborn babies that can be diagnosed as a result of products developed by CIE.
CIE has the mission of developing strategies and technologies for the active and integral investigation of the principal causes of the pathologies of the Cuban population.
Founded on September 7, 1987, by Fidel Castro, it reflects the Cuban policy of developing scientific and research centers that benefit the Cuban population and that are of particular relevance to the needs of Third World nations.
Commentaries
- Welcome to a new edition of the Jazz Place
- Minister Bruno Rodríguez: No Cuban family has escaped the impact of the US blockade
- RHC's national and international news stories Nov. 6
- Successive US administrations have sought to suffocate the Cuban economy for purely political reasons
- Washington’s hostile Cuba policy amounts to a fierce economic, trade and financial blockade
- RHC's national and international news stories Nov. 5
6707624
- Max: 19729
- yesterday: 3773
- today: 2582
- online: 110
- total: 6707624
Radio Habana Cuba © 2015 V 1.1.19
MAKE A COMMENT